GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CVAC
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Friday for Curevac N.V. stock after losing 0%
(Updated on Apr 19, 2024)

Sell candidate since Apr 08, 2024 Loss -20.52% PDF

No changes to the price of Curevac N.V. stock on the last trading day (Friday, 19th Apr 2024). During the last trading day the stock fluctuated 5.51% from a day low at $2.36 to a day high of $2.49. The price has fallen in 6 of the last 10 days and is down by -20.26% for this period.

The stock lies in the lower of a wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $2.42 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -24.92% during the next 3 months and, with a 90% probability hold a price between $1.82 and $2.24 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

CVAC Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, April 18, 2024, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. The volume rose on the last day while price remained unchanged. This may be an early warning and the stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Curevac N.V. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.66 and $3.05. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Curevac N.V. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.130 between high and low, or 5.51%. For the last week, the stock has had daily average volatility of 7.37%.

Curevac N.V. is oversold on RSI14 (22). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CVAC) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect Curevac N.V. to open at $2.43, and during the day (based on 14 day Average True Range), to move between $2.27 and $2.61, which gives a possible trading interval of +/-$0.169 (+/-6.92%) up or down from last closing price. If Curevac N.V. takes out the full calculated possible swing range there will be an estimated 13.84% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $2.91, some $0.470 (19.26%) from the current price of $2.44, our system finds the risk reward not very attractive.

Is Curevac N.V. stock A Buy?

Curevac N.V. holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -5.124 Strong Sell Candidate Unchanged

Predicted Opening Price for Curevac N.V. of Monday, April 22, 2024

Fair opening price April 22, 2024 Current price
$2.43 ( 0.410%) $2.44

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for CVAC

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.56 4.92 %
R2 2.51 2.88 %
R1 2.48 1.63 %
Current price: 2.44
Support S1 2.38 -2.45 %
S2 2.35 -3.70 %
S3 2.30 -5.74 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.96 21.31 %
R2 2.94 20.49 %
R1 2.91 19.26 %
Current price 2.44
Support S1 0 .
S2 0 .
S3 0 .

FAQ

What is the symbol for Curevac N.V. Stock and on which exchange is it traded?
The symbol for Curevac N.V. is CVAC and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Curevac N.V. Stock?
Curevac N.V. holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Curevac N.V. Stock?
Curevac N.V. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Curevac N.V. Stock.

What's the current price of Curevac N.V. Stock?
As of the end of day on the 2024-04-19, the price of an Curevac N.V. (CVAC) share was $2.44.

What is the 52-week high and low for Curevac N.V. Stock?
The 52-week high for Curevac N.V. Stock is $12.36 and the 52-week low is $2.36.

What is the market capitalization of Curevac N.V. Stock?
As of the 2024-04-19, the market capitalization of Curevac N.V. is 546.275M.

When is the next earnings date for Curevac N.V.?
The upcoming earnings date for Curevac N.V. is Jun 04, 2024.
Click to get the best stock tips daily for free!

About Curevac N.V.

Curevac N.V. CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which has completed Phase 1 clinical trial for rabies virus glycoprotein; and CVSQIV, which is in Phase 1 cli... CVAC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT